The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ginkgo Bioworks Holdings Inc
NYSE:DNA
|
US |
|
V
|
Vail Resorts Inc
F:VAI
|
US |
|
Supremex Inc
TSX:SXP
|
CA |
|
G
|
Getlink SE
F:TNU3
|
FR |
|
PO Valley Energy Ltd
ASX:PVE
|
AU |
|
Otec Corp
TSE:1736
|
JP |
|
B
|
BioMarin Pharmaceutical Inc
F:BM8
|
US |
|
C
|
Cloudflare Inc
F:8CF
|
US |
|
BankUnited Inc
NYSE:BKU
|
US |
|
E
|
Endeavour Group Ltd
F:6BH
|
AU |
|
Hunan Warrant Pharmaceutical Co Ltd
SSE:688799
|
CN |
|
H
|
HL D&I Halla Corp
KRX:014790
|
KR |
|
CryptoStar Corp
XTSX:CSTR
|
CA |
|
L
|
London Stock Exchange Group PLC
SWB:LS4C
|
UK |
|
Frasers Logistics & Commercial Trust
SGX:BUOU
|
SG |
|
Genuine Parts Co
NYSE:GPC
|
US |
|
Styrenix Performance Materials Ltd
NSE:STYRENIX
|
IN |
|
U
|
UEM Edgenta Bhd
KLSE:EDGENTA
|
MY |
|
Lucara Diamond Corp
TSX:LUC
|
CA |
|
NVIDIA Corp
MIL:1NVDA
|
US |
|
JW Life Science Corp
KRX:234080
|
KR |
|
Aya Gold & Silver Inc
NASDAQ:AYA
|
CA |
|
N
|
Nexon Co Ltd
OTC:NEXOF
|
JP |
|
Daiwa House Industry Co Ltd
OTC:DWAHF
|
JP |
Ginkgo Bioworks Holdings Inc (DNA)’s 12-month stock price forecast through October 2027 has a consensus target of $7.14, implying 42% downside. The forecast is based on price targets from 3 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
DNA is 7.14 USD with a low forecast of 5.05 USD and a high forecast of 9.45 USD.
Over the last 5 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 21%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more